TerminatedNCT00701753
A Pharmacogenetic Investigation of Antipsychotics in Schizophrenia and Schizophrenia-Like Psychoses
Observational studyAges 19–65Canada
Understand this study
Who could participate?
This study is for people with schizophrenia. Listed age limits: 19 years to 65 years. Other eligibility criteria apply.
- Listed locations
- VancouverSee all locations and recruitment
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateMay 2008
- Recruitment status
- Terminated
- Enrollment listed in the registry
- 24
- Sponsor
- TheraGenetics Limited
- Sponsor type
- Unknown or unclear
- Study type
- Observational
- Intervention type
- Interview / survey / observational
- Locations
- Canada
- Age range
- From 19 Years to 65 Years
- Official registry ID
- NCT00701753
- Official title
Show the full official title
A Pharmacogenetic Investigation of Antipsychotics in Schizophrenia and Schizophrenia-Like Psychoses
Recruitment & locations
TerminatedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Vancouver
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is TheraGenetics Limited.
Who can participate?
This study is for people with schizophrenia. Listed age limits: 19 years to 65 years. Other eligibility criteria apply.
Is this study still recruiting?
The registry lists this study as terminated.
